Cargando…
Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report
BACKGROUND: Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delayed haemolytic anaemia occurred after initial clinical improvement and resolution...
Autores principales: | Raffray, Loic, Receveur, Marie-Catherine, Beguet, Mathilde, Lauroua, Pierre, Pistone, Thierry, Malvy, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203878/ https://www.ncbi.nlm.nih.gov/pubmed/25306236 http://dx.doi.org/10.1186/1475-2875-13-398 |
Ejemplares similares
-
Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome
por: Sereshki, Mohammad Mahdi Adib, et al.
Publicado: (2019) -
Antibodies to actin in autoimmune haemolytic anaemia
por: Felder, Kathrin M, et al.
Publicado: (2010) -
A RARE CAUSE OF RECURRENT HAEMOLYTIC ANAEMIA: CARBOPLATIN AND PACLITAXEL-INDUCED AUTOIMMUNE HAEMOLYTIC ANAEMIA
por: Yingchoncharoen, Pitchaporn, et al.
Publicado: (2023) -
Elasomeran: Autoimmune haemolytic anaemia: case report
Publicado: (2022) -
Tozinameran: Autoimmune haemolytic anaemia: case report
Publicado: (2022)